Clarithromycin Tablet, Film Coated, Extended Release
Product Images NDC 0591-2805

5 FDA label images from Actavis Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Clarithromycin (NDC 0591-2805). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Clarithromycin Er Tablets A065145 1)

1 (Clarithromycin Er Tablets A065145 1)
Clarithromycin 500 mg extended-release film-coated tablets packaging label from Actavis Pharma, Inc. The label shows a rectangular carton with the product name, strength, and dosage form prominently displayed. The label includes the company name and product NDC 0591-2805.*
FDA Label Image

2 (Clarithromycin Er Tablets A065145 2)

2 (Clarithromycin Er Tablets A065145 2)
Chemical structure of clarithromycin, showing the detailed molecular arrangement of its atoms and bonds.*
FDA Label Image

3 (Clarithromycin Er Tablets A065145 3)

3 (Clarithromycin Er Tablets A065145 3)
A line graph showing mean plasma concentration (mcg/mL) of clarithromycin over time after dosing (hours). Two dosing regimens are compared: clarithromycin extended-release 2 x 500 mg every 24 hours, and clarithromycin 500 mg every 12 hours. The graph displays concentration changes within 24 hours after dosing.*
FDA Label Image

1 (Clarithromycin Er Tablets A065145 4)

1 (Clarithromycin Er Tablets A065145 4)
Clarithromycin 500 mg extended-release film-coated tablets packaging label from Actavis Pharma, Inc. The image shows a white label with minimal text and a single triangular symbol in the center, indicating the product and strength.*
FDA Label Image

1 (Clarithromycin Er Tablets A065145 5)

1 (Clarithromycin Er Tablets A065145 5)
Label for clarithromycin extended-release tablets, USP, 500 mg, film-coated oral tablets. Contains 60 tablets, labeled for prescription use only. Manufactured for Teva Pharmaceuticals, Parsippany, NJ. Manufacturer lot and expiration coding area on the right side. Barcode and storage instructions included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.